Skip to main content
Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden flag Sweden · Delayed Price · Currency is SEK
420.00
+16.60 (4.12%)
Apr 29, 2026, 5:29 PM CET

STO:SOBI Revenue

In the year 2025, Swedish Orphan Biovitrum AB had annual revenue of 28.24B SEK with 8.50% growth. Swedish Orphan Biovitrum AB had revenue of 7.82B in the quarter ending December 31, 2025, with 5.19% growth.

Revenue
28.24B
Revenue Growth
+8.50%
P/S Ratio
4.82
Revenue / Employee
15.55M
Employees
1,862
Market Cap
139.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202528.24B2.21B8.50%
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioGaia AB 1.54B
Cereno Scientific AB 44.27M
EQL Pharma AB 425.75M
Dicot Pharma AB 200.00K
Orexo AB 26.00M
Enzymatica AB 53.90M
Nanexa AB 55.94M
Moberg Pharma AB 13.54M
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News